(Q50554731)

English

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands.

scientific article published in March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

type-1 diabetes

0 references

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

insulin detemir

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Richard F Pollock

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

object named as

J Jendle

2

0 references

author name string

W J Valentine

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

M Saraheimo

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

B Thorsteinsson

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

M Lammert

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

publication date

1 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

29

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

303-312

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

The economic and quality of life impact of hypoglycemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Fear and other disturbances of severe hypoglycaemia in children and adolescents with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03461.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2011.03461.X

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21951030

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50554731&oldid=1562137009"